UCSF Brain Tumor Center Clinical Trials
Our clinical trials evaluate a broad range of innovative therapies for both adults and children with brain tumors.
-
Recruiting
- Pediatrics
- On Hold
Conditions
Glioma
Astrocytoma
Oligodendroglioma
Ependymoma
Isocitrate Dehydrogenase (IDH)-Mutant Astrocytoma
Pleomorphic xanthoastrocytoma (grades II-III)
Pilocytic astrocytoma (grade I)
This is a pilot study to develop a liquid biomarker of hypermutation in glioma patients previously treated with the chemotherapy temozolomide.
Conditions
Glioma
Astrocytoma
Glioblastoma
Isocitrate Dehydrogenase (IDH)-Mutant Astrocytoma
Chordoma
Schwannoma (grade 1)
Craniopharyngioma
Oligodendroglioma
Meningioma
Pituitary Tumor
This observational study will collect data to better understand our patient population and their behavior around cannabis, as well as clinical outcomes that might be linked to the consumption of cannabis.
Conditions
Glioblastoma
Glioma
This is a multicenter phase III clinical trial comparing the combination of an implanted focused ultrasound device and carboplatin chemotherapy versus the standard-of-care second line chemotherapy with either lomustine or temozolomide.
Conditions
Glioma
Glioblastoma
This is a randomized, double-blind, placebo-controlled study designed to examine the impact of a custom-formulated, high CBD product on measures of anxiety, quality of life, and tumor progression and imaging stability in newly-diagnosed glioblastoma patients.